Long overdue lawsuits for the antacid drug, Zantac, are now to be consolidated in multidistrict litigation (MDL) in Florida’s Southern District in the United States District Court. This was initially formed on February 6 with just 15 cases. At least 126 cases are pending throughout the country in 21 districts with the expectation that more … Continue reading “Zantac Cancer Lawsuits Move to MDL Phase”
Zantac May Have Caused Cancer: What You Can Do About It
In September of 2019 the FDA made an announcement that Zantac, the over-the-counter antacid, contains a chemical that causes cancer in humans. Later that year the project was pulled from all the US markets by all the manufacturers. We’re investigating claims against the manufacturer Zantac for causing cancer to our clients. If you or someone … Continue reading “Zantac May Have Caused Cancer: What You Can Do About It”
Zantac Recalls
Thanks to decades of regulatory oversight and pharmacovigilance, we tend to take for granted the quality and safety of our most used medicines. Sometimes, though, the challenges and complexities of ensuring this peace of mind are thrown into the spotlight. Recently, potentially carcinogenic nitrosamine impurities were found to be present in commercially available drug products. … Continue reading “Zantac Recalls”
Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-Nitrosodimethylamine (NDMA) Impurity
Jan 8, 2020 Audience: Consumer, Health Professional, Pharmacy January 8, 2020 — Denton Pharma, Inc. dba Northwind Pharmaceuticals, an affiliate of Northwind Pharmaceuticals, LLC (“Northwind”) today announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300mg, to the consumer level. The recall is in response to the manufacturer’s recall of all unexpired … Continue reading “Denton Pharma, Inc. dba Northwind Pharmaceuticals Voluntarily Recalls All Unexpired Lots of its Ranitidine Tablets and Ceases Distribution, Due to Possible Presence of N-Nitrosodimethylamine (NDMA) Impurity”
Zantac (Ranitidine) Cancer Lawsuits
Heartburn is a common, but often uncomfortable complaint, which in some cases can be controlled by modifying the diet. It is caused when acid refluxes back through the esophagus brought on by the consumption of some types of food and drink and certain medications as well. Because it is uncomfortable, pharmaceutical companies look for drug … Continue reading “Zantac (Ranitidine) Cancer Lawsuits”
Potential Zantac Plaintiffs
Prospective Zantac plaintiffs will include anyone who used Zantac on a regular basis for any extended period of time and was subsequently diagnosed with cancer. The strongest plaintiffs will be those diagnosed with specific types of cancer that are closely linked to NDMA and the gastrointestinal system which Zantac impacts. These include: Liver cancer Stomach … Continue reading “Potential Zantac Plaintiffs”
Does Zantac Cause Cancer?
In April 2019, an independent pharmaceutical testing lab, Valisure, conducting quality and safety testing and analysis on Zantac and its generic equivalents. The Valisure testing found that ranitidine (the active ingredient in Zantac) contained shockingly high levels of a toxic chemical called NDMA. NDMA (N-nitrosodimethylamine) is a chemical byproduct that results from certain modern manufacturing … Continue reading “Does Zantac Cause Cancer?”
